Argenx
ARGX
#564
Rank
C$52.74 B
Marketcap
$882.09
Share price
-0.48%
Change (1 day)
41.22%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Argenx (ARGX) - Total debt

Total debt on the balance sheet as of June 2024 : C$48.07 Million

According to Argenx 's latest financial reports the company's total debt is C$48.07 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Argenx - Total debt on balance sheet (from 2017 to 2020)

Total debt by year

Year Total debt Change
2022-12-31C$16.86 M15.4%
2021-12-31C$14.61 M-3.52%
2020-12-31C$15.14 M41.43%
2019-12-31C$10.7 M
2018-12-31N/A
2017-12-31N/A
2013-12-31N/A-100%
2012-12-31C$2.94 M1.6%
2011-12-31C$2.89 M